Related Experiment Video
Updated: Mar 22, 2026
14:35
Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs
Published on: April 17, 2021
9.2K
Summary
Iron deficiency in chronic heart failure patients worsens prognosis, leading to reduced quality of life and increased hospitalizations. Treating this iron deficit, particularly with intravenous iron, can improve outcomes.
Area of Science:
- Cardiology
- Internal Medicine
- Biochemistry
Background:
- Iron deficiency is a common comorbidity in chronic heart failure (CHF).
- It is linked to poorer patient prognosis, including reduced quality of life and increased rehospitalizations.
- Iron metabolism in CHF is complex, with distinctions between absolute and functional iron deficiency.
Purpose of the Study:
- To highlight the significance of iron deficiency in CHF.
- To discuss the current understanding of iron metabolism in CHF patients.
- To review the treatment strategies for iron deficiency in CHF.
Main Methods:
- Review of existing literature and clinical trial data on iron deficiency in CHF.
- Analysis of the prevalence and impact of iron deficiency and anemia in CHF.
- Evaluation of treatment efficacy, focusing on intravenous iron administration.
Main Results:
- Iron deficiency, rather than anemia, is critically associated with worse outcomes in CHF.
- Intravenous iron administration has shown positive results in clinical trials like FERRIC HF, FAIR HF, and CONFIRM HF.
- Per-oral iron treatment has less established efficacy compared to intravenous iron.
Conclusions:
- Addressing iron deficiency is crucial for improving the prognosis of patients with chronic heart failure.
- Intravenous iron therapy is a promising treatment approach for iron deficiency in CHF.
- Further research is needed, as current clinical trials have not yet analyzed mortality influences.
Related Concept Videos
01:27Heart Failure I: Introduction
1.2K
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
1.2K
01:30Heart Failure V: Medical Management
506
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
506
01:29Heart Failure II: Pathophysiology
1.3K
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.3K
01:30Heart Failure VII: Nursing Interventions
677
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
677
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
1.4K
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
1.4K
01:30Heart Failure IV: Classification and Diagnostic Evaluation
565
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
565